Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer

August 26, 2016 updated by: James Wrobel, DPM, MS, University of Michigan

Multi-material, Layer, and Density Insoles for a Patient-specific Approach to Shear and Pressure Reduction in the Treatment and Prevention of Diabetes-related Foot Ulcer

In this pilot study, the first objective is to bench test a novel shear reducing insole and compare it to current standard insoles and shoes. The second objective is to study twenty-seven insensate diabetes patients with pre-ulcerative foot callus to examine for changes in spatial temporal gait including gait initiation, risk of falling, static and dynamic balance, and plantar temperature response to walking and consecutive plantar stress in both footwear conditions.

Study Overview

Detailed Description

Device Description: The Dynamic Foot Orthosis (DFO) is designed with a rolling link mechanism at the distal 3rd. It is designed to reduce sliding friction and torque at the metatarsal heads in addition to decreasing compressive forces that is accomplished by the conventional multi-durometer FOs. The relative sliding motion of two compliant surfaces over each other allows some deformation horizontally and lowers frictional resistance. The DFO addresses the friction element by accommodating the normal sliding and rolling motion at the distal 3rd of the foot during gait. Additionally, the DFO has a silicone layer at the metatarsal head and the remainder of the anterior section made of 2 separated orthotic layers that slide over each other. This provides an articulating surface to provide a relative motion between the orthotic segments while transmitting load.

Study Objectives: In this pilot study, the first objective is to bench test a novel shear reducing insole and compare it to current standard insoles and shoes. The second objective is to study twenty-seven insensate diabetes patients with pre-ulcerative foot callus to examine for changes in spatial temporal gait including gait initiation, risk of falling, static and dynamic balance, and plantar temperature response to walking and consecutive plantar stress in both footwear conditions.

Study Design: This is an interventional study. For objective one, changes in compression stiffness and static coefficients of friction will be measured using a force dynamometer in the lab of Professor Albert Shih. A test platform will be built to evaluate the performance of the shear reduction shoe sole design and characteristic of the force, in two directions parallel (shear) and perpendicular to the ground, and the associated deformation under the steady-state and impulse conditions.

For objective two, diabetes patients presenting to the Michigan Orthotics and Prosthetics Center for fabrication and dispensing of diabetic shoes and innersoles will be invited to participate. Twenty-seven insensate diabetes patients with pre-ulcerative foot callus will be enrolled. Patients will wear body worn sensors (LegSys) to measure changes in spatial-temporal gait and static and dynamic balance parameters prior and post usage of the insoles. To reduce the effects of learning from naïve use of novel footwear, the testing sequence between the experimental and standard footwear will be randomized. We will examine increase on foot temperature over 200 steps of continuous walking using the DFO and using standard insoles. We will also examine if the thermal changes are mediated by autonomic neuropathy as measured by sudomotor function. The footwear testing sequence will be randomized and an acclimatization procedure will be followed in an effort to minimize the potential effects of cumulative plantar temperature responses to walking and footwear conditions. We will also examine static balance by measuring center of mass with eyes open and eyes closed condition.

Outcome Measures: For objective one, the primary endpoints will be the compression stiffness and static coefficients of friction. For objective two, plantar foot temperature changes in regions-of-interest in response to walking 200 steps will be measured in each footwear condition and compared to baseline. Other outcome measures include gait analysis, including gait initiation, gait speed, double support time, medial and lateral center of mass displacement, and inter-cycle variability under single and dual task conditions. This will be measured during each footwear condition. Static balance will also be measured in each footwear condition. Using the Romberg's test, we will also assess center of mass displacement and reciprocal hip and ankle motion under eyes open and closed conditions. Sudomotor function will be measured by electrical sweat conductance (ESC), as expressed in microSiemens (µS).

Safety Evaluation: All subjects who sign the informed consent form and are determined to be eligible for treatment will be included in the analysis of safety. Collection, classification and summary analysis of adverse events will be performed.

Duration of Participation: One visit lasting approximately 1 hour.

Duration of Study: One year

Inclusion Criteria: Patients will be included if they have diabetes and have been referred for diabetic shoes. They will also be insensate with pre-ulcerative plantar callus or previous plantar foot ulcer.

Exclusion Criteria: Patients will be excluded if they are unable to independently walk 100 feet, lower extremity prosthesis user, have active cellulitis, foot ulcer, or Charcot foot.

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48104-6768
        • Michigan Orthotics and Prosthetics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients will be included if they have diabetes and have been referred for diabetic shoes. They will also be insensate with pre-ulcerative plantar callus or previous plantar foot ulcer.

Exclusion Criteria:

  • Patients will be excluded if they are unable to independently walk 100 feet, lower extremity prosthesis user, have active cellulitis, foot ulcer, or Charcot foot.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard innersole

Per sequence cross over design. Order of testing innersoles was randomized and each testing condition lasted 15 minutes.

The industry standard diabetic innersole will be used as the active comparator

Experimental: Diabetic Foot Orthotic
The Dynamic Foot Orthosis (DFO) is designed with a rolling link mechanism at the distal 3rd to reduce sliding friction at the metatarsal heads in addition to decreasing compressive forces. The relative sliding motion of two compliant surfaces over each other allows some deformation horizontally and lowers frictional resistance. The DFO addresses the friction element by accommodating the normal sliding and rolling motion at the distal 3rd of the foot during gait. Additionally, the DFO has a silicone layer at the metatarsal head and the remainder of the anterior section made of 2 separated orthotic layers that slide over each other. This provides an articulating surface to provide a relative motion between the orthotic segments while transmitting load.
The Dynamic Foot Orthosis (DFO) is designed with a rolling link mechanism at the distal 3rd to reduce sliding friction at the metatarsal heads in addition to decreasing compressive forces. The relative sliding motion of two compliant surfaces over each other allows some deformation horizontally and lowers frictional resistance. The DFO addresses the friction element by accommodating the normal sliding and rolling motion at the distal 3rd of the foot during gait. Additionally, the DFO has a silicone layer at the metatarsal head and the remainder of the anterior section made of 2 separated orthotic layers that slide over each other. This provides an articulating surface to provide a relative motion between the orthotic segments while transmitting load.
Other Names:
  • shear reducing innersole

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plantar Foot Temperature Changes in Regions-of-interest in Response to Walking
Time Frame: baseline and after 200 steps in each condition, this is a single visit study expected to last one hour
Plantar foot temperature changes in regions-of-interest in response to walking 200 steps will be measured in each footwear condition and compared to baseline.
baseline and after 200 steps in each condition, this is a single visit study expected to last one hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait Initation - Single Task
Time Frame: during each foot wear condition up to 30 minutes
The number of steps taken to reach steady state walking under single task. Single task means walking without a simultaneous mental task.
during each foot wear condition up to 30 minutes
Gait Initiation - Dual Task
Time Frame: during each foot wear condition up to 30 minutes
The number of steps taken to reach steady state walking under dual task. Dual task used a simultaneous mental task while walking.
during each foot wear condition up to 30 minutes
Stride Velocity - Dual Task
Time Frame: during each foot wear condition up to 30 minutes
Stride velocity during steady state dual task. Dual task used a simultaneous mental task while walking.
during each foot wear condition up to 30 minutes
Double Support Time Single Task
Time Frame: during each foot where condition up to 30 minutes
percentage of stride time spent in double support time during gait initiation. Double support time refers to the time spent with both feet on the ground. Single task means walking without a simultaneous mental task.
during each foot where condition up to 30 minutes
Double Support Time Dual Task Gait Initiation
Time Frame: during each foot where condition up to 30 minutes
percentage of stride time spent in double support time during dual task conditions and during gait initiation. Double support time refers to the time spent with both feet on the ground. Dual task used a simultaneous mental task while walking.
during each foot where condition up to 30 minutes
Medial and Lateral Center of Mass Displacement Single Task
Time Frame: under each foot where condition up to 30 minutes
Mediolateral (side-to-side) center of mass displacement with displacement in deg2 (degrees squared) under single task gait conditions. Single task means walking without a simultaneous mental task.
under each foot where condition up to 30 minutes
Medial and Lateral Center of Mass Displacement Dual Task
Time Frame: both footwear conditions up to 30 minutes
Mediolateral (side-to-side) center of mass displacement in deg2 (degrees squared) under dual task gait. Dual task used a simultaneous mental task while walking.
both footwear conditions up to 30 minutes
Gait Speed Variability Single Task
Time Frame: both footwear conditions up to 30 minutes
Gait speed variability (estimated using coefficient and variation of stride velocity) Single task means walking without a simultaneous mental task.
both footwear conditions up to 30 minutes
Gait Speed Variability Dual Task
Time Frame: Both footwear conditions up to thirty minutes
Gait speed variability (estimated using coefficient and variation of stride velocity) Dual task used a simultaneous mental task while walking.
Both footwear conditions up to thirty minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stride Velocity - Single Task
Time Frame: during each foot wear condition up to 30 minutes
Stride velocity steady state gait single task. Single task means walking without a simultaneous mental task.
during each foot wear condition up to 30 minutes
Sudomotor Function
Time Frame: at baseline, this is a single visit study expected to last one hour
Sudomotor function will be measured by electrical sweat conductance (ESC), as expressed in microSiemens (µS).
at baseline, this is a single visit study expected to last one hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James Wrobel, DPM, MS, UMHS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

April 12, 2013

First Submitted That Met QC Criteria

April 30, 2013

First Posted (Estimate)

May 1, 2013

Study Record Updates

Last Update Posted (Estimate)

October 6, 2016

Last Update Submitted That Met QC Criteria

August 26, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Foot

Clinical Trials on Standard innersole

3
Subscribe